Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice and the pharmacokinetics of its active ingredients under conditions of glycerol fatty acid ester as emulsifiers
- PMID: 35970315
- DOI: 10.1016/j.jep.2022.115625
Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice and the pharmacokinetics of its active ingredients under conditions of glycerol fatty acid ester as emulsifiers
Abstract
Ethnopharmacological relevance: Valeriana plant roots have traditionally been used to treat central nervous system-related disorders in European countries. Among this genus, the Japanese Pharmacopoeia registers the dried roots of V. fauriei Briq. (VF). However, insufficient pharmacological data are available for this species.
Aim of the study: We investigated the sedative effects of VF extract in a murine caffeine-induced insomnia model as well as the active ingredients and their pharmacokinetics to determine its basic pharmacological action mechanisms under conditions glycerol fatty acid ester is used as emulsifiers.
Materials and methods: A murine insomnia model was created by caffeine. Samples derived from the ethanol extract of VF were administered per oral (p.o.), and caffeine was injected intraperitoneally (i.p.). Pentobarbital was injected i.p. and the sleep latency and duration were measured. To confirm the mechanism of action of VF, flumazenil, a specific γ-aminobutyric acid receptor type A (GABAA receptor) antagonist, was administered (i.p.) immediately prior to the sample administration. We examined the pharmacokinetic profiles of the active ingredients in the plasma, brain, urine, and feces of mice after the administration (p.o and intravenous (i.v.)) of VF samples.
Results: VF extract (5 g as VF/kg, p.o.) significantly shorten sleep latency and prolonged pentobarbital-induced sleep in caffeine-induced insomnia mice, partially mediated via the GABAergic nervous system, although a higher dose (10 g as VF/kg, p.o.) was required to exhibit the significant effects in normal mice. Kessyl glycol diacetate (KGD), the main constitutive compound in VF, did not shorten sleep latency but exhibited the same sleep prolonged effect at a dose related to VF extract. The concentration of kessyl glycol 8-acetate (KG8) in the plasma was higher than that of KGD in mice treated (p.o.) with VF extract. The profiles of brain concentrations of KGD and KG8 were similar to those in the plasma, and approximately 20% of those in the plasma were distributed throughout the brain. The excretions of KGD and KG8 in urine and feces was slightly detected, and an unknown large peak related to KG8 was detected in the urine of mice administered with VF extract by HPLC-MS/MS analysis.
Conclusions: VF exhibits more sedative effects under stressed conditions, such as insomnia, and the major active ingredients are KGD and its metabolite KG8, which are distributed from the blood circulation into the brain by simple diffusion. KG8 is further metabolized into other metabolites that are easily excreted in the urine.
Keywords: Capsaicin; Diazepam; Distribution; Kessyl glycol; Kessyl glycol 2-acetate; Kessyl glycol 8-acetate; Kessyl glycol diacetate; Sedative; Umbelliferone; Valeriana fauriei root; γ-aminobutyric acid receptor type a.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: T.M. received grant support from Kuki Sangyo, Tsumura, and Kobayashi Pharmaceutical. M.O. and Y.M. are the employees of Kuki Sangyo.
Similar articles
-
Binding activity of Valeriana fauriei root extract on GABAA receptor flunitrazepam sites and distribution of its active ingredients in the brain of mice - A comparison with that of V. officinalis root.J Ethnopharmacol. 2021 Oct 5;278:114262. doi: 10.1016/j.jep.2021.114262. Epub 2021 Jun 8. J Ethnopharmacol. 2021. PMID: 34116188
-
Inhibitory effects of Valeriana fauriei root extract on serotonin uptake in vitro caused by the interaction among its active ingredients including a new compound.J Ethnopharmacol. 2025 Feb 27;342:119374. doi: 10.1016/j.jep.2025.119374. Epub 2025 Jan 18. J Ethnopharmacol. 2025. PMID: 39832628
-
Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents.J Ethnopharmacol. 2012 Aug 30;143(1):213-20. doi: 10.1016/j.jep.2012.06.026. Epub 2012 Jun 27. J Ethnopharmacol. 2012. PMID: 22750453
-
[Valerian as a sleeping aid?].Tidsskr Nor Laegeforen. 2002 Dec 10;122(30):2857-9. Tidsskr Nor Laegeforen. 2002. PMID: 12569707 Review. Norwegian.
-
Therapeutic potential of hypnotic herbal medicines: A comprehensive review.Phytother Res. 2024 Jun;38(6):3037-3059. doi: 10.1002/ptr.8201. Epub 2024 Apr 10. Phytother Res. 2024. PMID: 38595123 Review.
Cited by
-
Use of machine learning to identify risk factors for insomnia.PLoS One. 2023 Apr 12;18(4):e0282622. doi: 10.1371/journal.pone.0282622. eCollection 2023. PLoS One. 2023. PMID: 37043435 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
